DE60322913D1 - Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren - Google Patents

Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren

Info

Publication number
DE60322913D1
DE60322913D1 DE60322913T DE60322913T DE60322913D1 DE 60322913 D1 DE60322913 D1 DE 60322913D1 DE 60322913 T DE60322913 T DE 60322913T DE 60322913 T DE60322913 T DE 60322913T DE 60322913 D1 DE60322913 D1 DE 60322913D1
Authority
DE
Germany
Prior art keywords
peptides
fiber
self
interacting
arranging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322913T
Other languages
English (en)
Inventor
Derek Woolfson
Maxim G Ryadnov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sussex
Original Assignee
University of Sussex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sussex filed Critical University of Sussex
Application granted granted Critical
Publication of DE60322913D1 publication Critical patent/DE60322913D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Multicomponent Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
DE60322913T 2002-09-06 2003-09-08 Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren Expired - Lifetime DE60322913D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0220805.6A GB0220805D0 (en) 2002-09-06 2002-09-06 Peptide monomers and protein structures
PCT/GB2003/003900 WO2004022584A1 (en) 2002-09-06 2003-09-08 Fiber-shaping peptides capable of interacting with self-assembling peptides

Publications (1)

Publication Number Publication Date
DE60322913D1 true DE60322913D1 (de) 2008-09-25

Family

ID=9943665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322913T Expired - Lifetime DE60322913D1 (de) 2002-09-06 2003-09-08 Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren

Country Status (9)

Country Link
US (1) US7507790B2 (de)
EP (1) EP1534741B1 (de)
JP (1) JP4544997B2 (de)
AT (1) ATE404581T1 (de)
AU (1) AU2003264736A1 (de)
DE (1) DE60322913D1 (de)
DK (1) DK1534741T3 (de)
GB (1) GB0220805D0 (de)
WO (1) WO2004022584A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201306634D0 (en) 2013-04-11 2013-05-29 Univ Bristol Cage-like particles
WO2016129656A1 (ja) * 2015-02-12 2016-08-18 国立大学法人岩手大学 哺乳動物細胞に対する外来遺伝子の導入効率の向上剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB9922013D0 (en) * 1999-09-17 1999-11-17 Univ Sussex Peptides

Also Published As

Publication number Publication date
US20060155112A1 (en) 2006-07-13
ATE404581T1 (de) 2008-08-15
US7507790B2 (en) 2009-03-24
WO2004022584A1 (en) 2004-03-18
EP1534741B1 (de) 2008-08-13
AU2003264736A1 (en) 2004-03-29
GB0220805D0 (en) 2002-10-16
JP4544997B2 (ja) 2010-09-15
DK1534741T3 (da) 2008-12-15
JP2006513985A (ja) 2006-04-27
EP1534741A1 (de) 2005-06-01

Similar Documents

Publication Publication Date Title
CY1119106T1 (el) Αντισωματα εναντι masp-2
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE444969T1 (de) Dimerisiertes peptid
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
ATE428727T1 (de) Neue, an den erythropoietinrezeptor bindende peptide
DE60238993D1 (de) Hybrid und tandemproteine von neisseria sp
DK1625209T3 (da) Kimære immunoglobulin-monomer-dimer-hybrider
EE200300264A (et) ß-amüloidpeptiidi äratundvad humaniseeritud antikehad
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
WO2003074546A3 (de) Streptavidin-bindungspeptid
ATE353336T1 (de) Neues peptid mit angiotensinkonvertase hemmender wirkung
ATE323722T1 (de) Antimikrobiell wirkendes peptid
ATE370160T1 (de) Peptide mit affinität zu gp120, und ihre verwendungen
DE60322913D1 (de) Faserformgebende peptide, die mit selbstanordnenden peptiden interagieren
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
WO2005007682A3 (en) A peptide and a pharmaceutical composition, and their medical applications
DE60229883D1 (de) Biologisch aktive peptide
NO20032963D0 (no) Peptidforbindelser
NO20044105L (no) VEGF peptider og anvendelse derav
DE60239390D1 (de) Neues, natürliches antibakterielles peptid, die füssen verwendung
ATE443715T1 (de) Polypeptide aus haemophilus influenza
DE808846T1 (de) Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren
ITTO20010795A0 (it) Polipeptide isolato basato sulla sequenza della proteina p17 utile come vaccino anti-hiv.
SE0203226D0 (sv) Immunoglobulin bindning site

Legal Events

Date Code Title Description
8364 No opposition during term of opposition